Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Sage Therapeutics, Inc. | d862496dex321.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | d862496dex311.htm |
| EX-21.1 - EX-21.1 - Sage Therapeutics, Inc. | d862496dex211.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | d862496dex312.htm |
| EX-10.23 - EX-10.23 - Sage Therapeutics, Inc. | d862496dex1023.htm |
| EX-10.20 - EX-10.20 - Sage Therapeutics, Inc. | d862496dex1020.htm |
| EX-10.22 - EX-10.22 - Sage Therapeutics, Inc. | d862496dex1022.htm |
| EX-10.21 - EX-10.21 - Sage Therapeutics, Inc. | d862496dex1021.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Sage Therapeutics, Inc. | Financial_Report.xls |
| 10-K - FORM 10-K - Sage Therapeutics, Inc. | d862496d10k.htm |
| EX-10.24 - EX-10.24 - Sage Therapeutics, Inc. | d862496dex1024.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-197498) of Sage Therapeutics, Inc. of our report dated March 6, 2015 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, MA
March 6, 2015